First biomarker for multiple sclerosis found

London, March 29 (ANI): Scientists have discovered the first biomarker for multiple sclerosis (MS) that might predict which patients will respond to a standard therapy and which will not.

Researchers at the University of Alabama at Birmingham (UAB), along with researchers at Stanford University, found that patients with a particular type of T helper immune cells responded well to interferon-ß, the usual first-line therapy for the disease, while those with a different T helper immune-cell type either did not respond or experienced worsening symptoms.

“Interferon-ß is typically the first therapeutic choice for most MS patients, but there is a subset of about 30 percent of patients for whom it does not work and may make the patient worse,” said Chander Raman, associate professor in the Division of Clinical Immunology and Rheumatology and lead investigator of the study.

“Our findings, in both animal and human models, indicate that the type of T helper cell present is the determining factor in predicting whether interferon-ß will be effective,” Raman added.

Raman suggests this might be another rung on the ladder leading to personalized medicine, in which therapies are based on an individual’s physiology and genetic makeup and the nature of disease.

“When our findings are verified in an expanded human trial, a simple blood test could be used to determine which type of T helper cell is predominantly responsible for the disease in an MS patient, enabling clinicians to provide the proper therapy from the beginning of treatment and eliminate the guesswork,” Raman said.

The researchers examined T helper Type 1 cells and T helper Type 17 cells in an animal model for multiple sclerosis. Both Th1 and Th17 cells are major initiators of MS and important in disease severity. The researchers found that interferon-ß was effective in mice with disease initiated by Th1 cells, but worsened disease initiated by Th17 cells.

The findings were replicated with striking consistency in analysis of human-patient serum with relapsing-remitting multiple sclerosis, the most common form of the disease.

“This research reinforces the concept that diseases have certain signatures that help define their origin and give us glimpses of how they manifest in our bodies. The more we understand these signatures, the more likely we will be able to intervene at a critical junction and design and provide therapies that lessen or cure disease,” said Raman.

The findings have been published online March 28 in Nature Medicine. (ANI)

Genetic variation linked to protection against sudden cardiac arrest

Washington, Mar 27 (ANI): A genetic variation associated with lower risk of sudden cardiac arrest has been found by physician-scientists at the Cedars-Sinai Heart Institute.

The finding will be published in Public Library of Science (PloS One).

The discovery came from a genome-wide association study, which examines the entire set of human genes to detect possible links between genetic variations and specific conditions or diseases.

In the study, the Cedars-Sinai Heart Institute researchers compared the genetic makeup of 424 subjects who had experienced sudden cardiac arrest to the DNA of 226 control subjects who had no history of the disorder. All patients had a history of coronary artery disease, which commonly underlies sudden cardiac arrest.

Based on a comparison of the two groups, a genetic variation at the location of the GPC5 gene – a genetic sequence called rs3864180 – was found to be associated with a reduced risk of sudden cardiac arrest.

“If you have this genetic variation in your DNA, it appears that you may have a 15 percent lower likelihood of sudden cardiac arrest,” said Sumeet S. Chugh, M.D., associate director of the Cedars-Sinai Heart Institute, holder of The Pauline and Harold Price Chair in Cardiac Electrophysiology Research, and one of the senior authors of the study.

“This kind of genetic analysis is not aimed at identifying a single big gene defect or mutation,” he said. “The goal is to identify a series of smaller novel gene defects that, when grouped together, collectively result in either a protective effect or an increased susceptibility to sudden cardiac arrest.” (ANI)

Scientists unveil biological process that spurs blood vessels growth

Washington, Sept 15 (ANI): In a novel study, scientists from University of North Carolina and the College of Arts and Sciences have identified a novel mechanism that triggers blood vessel growth.

They have found that vascular networks form and expand by “sprouting” similar to the way trees grow new branches.

The process allows fresh oxygen and nutrients to be delivered to tissues, whether in a developing embryo or a cancerous tumour.

Earlier, scientists believed that the molecular signals to form new sprouts came from outside the vessel.

However, the new study has shown that signals can also come from within the blood vessel, pushing new blood vessel sprouts outward.

While analysing mouse embryonic stem cells and mouse retinas, the researchers found that defects in a protein called Flt-1 lead to abnormal sprouts and poor vessel networks.

Other research recently showed that levels of Flt-1 protein are particularly low in the dilated and leaky blood vessels that supply tumours with oxygen.

“The blood vessels themselves seem to participate in the process guiding the formation of the vascular network,” said senior study author Dr Victoria L. Bautch, professor of biology at UNC.

“They do not just passively sit there getting acted upon by signals coming from the outside in. Rather, they produce internal cues that interact with external cues to grow,” she added.

The growth of new blood vessels can be stimulated by cascades of events within the cell – known as pathways – the most notable of which centers around the three proteins Flt-1, Flk-1 and VEGF.

During the study, the researchers mixed two different types of mouse embryonic stem cells – one batch with normal Flt-1 protein levels, the other with no Flt-1 protein.

They found that the genetic makeup of the area at the base of the sprout – rather than at the sprout itself – determined whether the sprout behaved normally or abnormally.

“The cells on each side of sprout produce and send out the soluble form of the protein, blocking the sprout from forming anywhere but in one spot and in one direction,” says Bautch. “

So when the sprout first forms, instead of flopping back onto its parent vessel, it has a corridor to push it forward away from the parent,” she added.

The findings have been published in the journal Developmental Cell. (ANI)

Genetic glitch could lead to targeted therapy for neuroblastoma

London, June 25 (ANI): Scientists from University of Florida claim to have identified a genetic glitch responsible for the development of fatal childhood cancer.

They hope that the new discovery may provide a novel approach for developing treatments that target the disease also known as neuroblastoma.

“What makes our study so important is that although neuroblastoma accounts for 7 percent of childhood cancers, it is responsible for 15 percent of deaths in children with cancer,” Nature quoted Dr Wendy London, a research associate professor of epidemiology, biostatistics and health policy research at the UF College of Medicine and a member of the UF Shands Cancer Centre as saying.

“This paper adds yet another gene in the pathway that could lead to tumorigenesis (tumour formation) of neuroblastoma,” she added.

Under the supervision of Dr John J. Maris, director of the Cancer Centre at The Children’s Hospital of Philadelphia, researchers team conducted a genome-wide study to identify errors in DNA that could be associated with neuroblastoma.

They looked at the genetic makeup of 846 patients with neuroblastom and 803 healthy patients in a control group and found that a glitch called a “copy number variation” in a single chromosome is associated with neuroblastoma.

The copy number variation has to do with the gain, loss or duplication of snippets of DNA.

“This is part of series of papers that creates the bigger picture, an understanding of the genetic mechanisms that lead to neuroblastoma,” said London.

“We are searching for genetic targets to treat with therapy,” she added.

The researchers have also found gene called BARD1, six single-nucleotide polymorphisms – variations in tiny pieces of DNA – were also associated with neuroblastoma. (ANI)

HIV’s ‘hide and seek’ could make it weaker

Melbourne, May 9 (ANI): HIV usually plays a game of hide and seek to dodge the immune system, but a new study has claimed that such playfulness actually makes the deadly virus vulnerable at times, according to an Australian study.

The finding could offer insights into the treatment of HIV during the early stages of infection.

At the time of entering a new host, HIV includes a form that researchers call escape mutant.

Although the escape mutant virus is better at evading our immune system, it is weaker and replicates slower than the wild-type form.

“When HIV infects a new host it needs to adapt to this new environment,” ABC News quoted lead author and PhD student Liyen Loh, of the Department of Immunology and Microbiology at The University of Melbourne, as saying.

She added: “The mutations often revert to the original wild-type virus, allowing the virus to regain a fitter state, or the changes may be retained, depending on the individual’s immune system. This explains why some individuals have better clinical outcomes than others.”

In the study, the researchers from the University of Melbourne and the University of Sydney analysed the evolution of the virus using macaque monkeys by infecting them with different quantities of wild-type SIV (the non-human equivalent of HIV) and escape mutant SIV.

They then measured the growth of the virus for the next three months to find out how much time the escape mutant form took to revert back to its fitter wild-type state.

“In the absence of immune pressure the virus will not stay in its weakened state, because it is not beneficial for the virus,” said Loh.

It was discovered that in animals infected with the escape mutant virus, it took 8 days for wild type to appear and it took 8 weeks for them to outnumber the escape mutant form.

The researchers also found that the genetic makeup of the virus affected how fast the virus adapts in the host.

“If (the macaques) get infected with purely one strain of virus it will take longer to adapt to the new host,” said Loh.

In her opinion, the study only focused on one structural part of the virus that mutates, and also claimed that there are many “other bits” that affect how the HIV evolves in an infected individual.

The study has been published in the PLoS journal Pathogens. (ANI)

Gene that switches on during epilepsy development identified

Washington, Apr 23 (ANI): Researchers at Wake Forest University School of Medicine have identified a gene that switches on during development of epilepsy.

The discovery made while studying mice may help explain how some people without a genetic predisposition to epilepsy can develop the disorder.

In a study published this month in the Journal of Neuroscience, senior researcher Dwayne W. Godwin, Ph.D., a professor of neurobiology and anatomy, and colleagues, report discovering that a gene, already known to predispose people who inherit an active form of it to certain forms of epilepsy, can actually be “switched on” in animals that do not appear to have inherited the active form, and therefore a genetic predisposition, to the condition.

The gene codes a calcium channel in the brain that underlies seizures, so the finding may reveal a mechanism by which epilepsy develops in those with no apparent genetic predisposition to it.

“Epilepsy is a terrible disorder that affects millions of kids and adults all over the world,” Godwin said.

“There are many different forms of epilepsy with different symptoms. We don’t know why some people acquire epilepsy – the cause isn’t always clear from the person’s genetic makeup. We do know that in some forms of epilepsy, once someone has a seizure they tend to have more. Our findings from this study suggest that something about the brain changes that can lead to this increased tendency to have a seizure. Our study shows that an important change occurs in calcium channels that help to transmit this abnormal activity throughout the brain,” the expert added.

Calcium channels come in a variety of forms throughout the body and are responsible for several key functions, depending on their placement and quantity. The calcium channels in the brain are normally embedded within the membrane of brain cells, where they allow passage of calcium ions into the cell and are responsible for the electrical activity of the brain.

The passage of calcium ions into cells determines how excitable the cells are, and how easily abnormal activity spreads through the brain.

If, as in epilepsy, a particular channel shows up where it is not supposed to or appears in too many or too few numbers, the function that channel is responsible for can become abnormal. Researchers know that during epileptic seizures, these calcium channels in the brain, responsible for generating electrical brain rhythms, become highly active.

For the study, researchers used a mouse model to observe changes in tissue from regions of the brain that are involved in seizures, the hippocampus and the thalamus. They measured these changes at different time intervals as the mice developed epilepsy. The researchers found that after an initial seizure, more of this particular kind of calcium channel begins to be expressed where it wasn’t before, and the presence of the channel caused brain activity to become increasingly abnormal and epileptic.

“Calcium channels underlie valuable functions. But in the wrong place, at the wrong time, or in the wrong amount, their presence can be disruptive. In the context of brain circuits, the brain cells that have too many copies of the channel get over excited and respond abnormally,” Godwin said.

While the hippocampus is usually targeted in studies of epilepsy, the new channels were being made in a region of the brain called the thalamus. The thalamus is connected to the hippocampus and is involved in the spread of seizures throughout the brain.

“Certain kinds of channels are normal and expected in the thalamus, but after an initial seizure more copies of a channel that isn’t normally found in this brain region begin to appear,” explained graduate student John Graef, the first author on the study.

“The brain activity then becomes dominated by the new copies of this channel. It helps explain how seizures can develop and spread,” the expert added. (ANI)

Personalised cancer treatment comes closer to reality

London, Apr 20 (ANI): Researchers have taken a step forward to bringing personalized cancer therapy within reach by using molecular profiling of the patients that can help identify specific treatments.

The study shows that molecular profiling of patients can identify specific treatments for individuals, helping keep their cancer in check for significantly longer periods, and in some cases even shrinking tumours.

During the research, the team recruited 66 patients at nine centres across the United States, including Scottsdale Heathcare.

All of the patients had previously experienced growth of their tumours while undergoing as many as two to six prior cancer treatments, including conventional chemotherapy.

However, after molecular profiling identified precise targets, new treatments were administered that resulted in patients experiencing significant periods of time when there was no progression of their cancer.

The treatments would be prescribed based on an individual’s specific genetic makeup. The type of drugs, dosages, their delivery and other treatment aspects – all are based on each patient’s individual medical needs.

The research team found that patients experienced varying levels of improvement. Among those with breast cancer, the period of progression-free survival increased for 44 percent of patients; for colorectal, 36 percent of patients; for ovarian, 20 percent of patients; and for miscellaneous cancers the improvement was seen in 16 percent of patients.

“With this trial, we are showing the power of personalized medicine using the tools we already have available to us,” said Dr. Von Hoff, Chief Scientific Officer of TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.

“As these tools become more precise and more effective, the value of personalized medicine will increase,” he added.

“This trial is evidence of an important breakthrough in the treatment of cancer,” said David D. Halbert, Chairman and CEO of Caris Diagnostics.

The molecular profiling for this research study was performed by Caris Diagnostics (Caris Dx) in Phoenix.

The study was presented at 100th annual meeting of the American Association for Cancer Research in Denver. (ANI)

Police free Berlin theft suspects over identical DNA

Berlin – Identical twins arrested on suspicion of burgling Berlin’s famous KaDeWe department store have been released because investigators cannot tell their DNA apart, justice officials said Wednesday.

DNA found at the scene was traced to one of the 27-year-old brothers, but police cannot tell which one because their genetic makeup is virtually the same, the Berlin prosecutors office said.

The two men were taken into custody last month on suspicion of stealing jewellery and watches worth millions of euros from the store on January 27. Police are still searching for a third man.

None of the valuables has been found.

“A spokesman for the prosecutor’s office said the suspects’ “DNA is virtually identical and impossible to differentiate between using current methods of testing.”

Other evidence turned up by police during their inquiries failed to determine whether one or both of the brothers was at the scene. Police said they were continuing their investigations.

The KaDeWe, or Kaufhaus des Westens, is a popular tourist attraction in Berlin. (dpa)

Just one ‘false’ amino acid can limit heart’s strength

Washington, March 6 (ANI): Scientists at the Heidelberg University Hospital in Germany have found that just one “false” amino acid can limit the strength of heart in zebrafish.

The researcher say that their finding attains significance as the fish have a genetic makeup similar to that of humans, and such defects could be critical for humans as well.

They point out that cardiac insufficiency is not just a disease that results from a heart attack or myocarditis, and that for young people, in particular, there is often an underlying genetic cause (cardiomyopathy).

The genetic variant that suffers from cardiomyopathy is called “Lazy Susan”, and got its nickname because of its slow blood flow.

When the researchers examined the muscle protein myosin light chain-1, which is involved in contraction of the heart muscle, they observed the crucial change in the amino acid Serine 195, which was lost through mutation.

The researchers say that this single change is sufficient to severely limit heart function.

Given that about 70 percent of the genes of zebrafish and humans are identical, the researchers say that these results are very important.

The Heidelberg cardiologists are currently planning to search for the same mutation in patients’ genes, hoping that their research may lead to new therapies for patients. (ANI)

Genetically mixed populations can help understand human diversity, origins: Expert

Washington, February 15 (ANI): A Penn State physical anthropologist says that genetic diseases and genetically mixed populations can prove useful in understanding human diversity and human origins.

“We wanted to get to a strategy to predict what a face will look like. We want to understand the path of evolution that leads to that part of the selection process,” said Mark D. Shriver, associate professor of biological anthropology.

He revealed that with an eye on pinpointing genes that influence the shape of the human face and head, he began with an online database of genes linked to disease-Online Mendelian Inheritance of Man.

If the symptoms of the disease involved the face or skull the gene implicated in the disease became a candidate for those facial traits, said the researcher.

Shriver says that the his approach works because, though he looked at genes implicated in disease, those same genes in a healthy person may also influence the same physical trait-length, width, shape, size-but within the range normal for healthy individuals.

The researcher highlights that fact that facial traits vary among humans, but do tend to group by population.

In general, according to him, West Africans have wider faces than Europeans and Europeans have longer faces than West Africans.

“There is a strong relationship between genetic ancestry and facial traits. Using individuals of combined ancestry, European and African, we can see how the target genes alter facial traits,” he told attendees at the 2009 Annual Meeting of the American Association for the Advancement of Science.

The study was concentrated on a combined sample of African Americans with West African and European ancestry, whose genetic makeup was known through DNA testing.

The researchers made it simpler by eliminating anyone with Native American ancestry, so that only two genetic pools were represented-West African and European.

They reported on a sample of 254 individuals using three-dimensional imaging, and measured the distances between specific portions of the face.

Each individual had provided a DNA sample.

“We started with 22 landmarks on the faces that could be accurately located in all the images,” said Shriver, adding that these landmarks might be the tip of the nose, the tip of the chin, the outer corner of the eye or other repeatable locations.

The research team then recorded the distances between all the points in all directions, in order to have a distance map of each of the faces.

From their DNA profiles, Shriver could determine the admixture percentages of each individual, how much of their genetic make up came from each group.

He could then compare the genetically determined admixture to the facial feature differences and determine the relative differences from the parental populations.

“This type of study, done on admixed populations shows that each person is a composite of their ancestors and that the range of facial features is a continuum,” says Shriver.

He and his colleagues observed that there was a very strong statistical correlation between the amounts of admixture and the facial traits.

“We chose to look at African Americans because they were a large enough and available admixed population. We are trying to solidify our understanding of the origins of humans and the evolutionary processes. Looking at admixed populations shows us the influence genes have and how they relate to physical features,” said Shriver. (ANI)

Inhalation therapy proves effective against cystic fibrosis

Washington, Feb 6 (ANI): By spraying amiloride into the lungs of young mice, scientists have successfully prevented the onset of cystic fibrosis lung disease in mice.

The researchers at Department of Paediatrics at Heidelberg University Hospital have demonstrated for the first time that preventative therapy for the lung disease is possible.

Attacking the root cause of the widespread hereditary disease, the mice in the study were given an inhalation treatment with the drug in the first days of life.

It was found that no thick mucus forms in the lungs and airway inflammation and chronic lung damage could be prevented.

Cystic fibrosis (CF) or mucosviscidosis or is the most common life-shortening genetic disease, caused by defects at a certain locations in the genetic makeup – a mutation in what is called the CFTR (“Cystic Fibrosis Transmembrane Conductance Regulator” gene).

The mutation leads to loss of salt and water and thus dehydration of the surfaces of the mucous membranes in the lungs, intestines, and other organs.

Amiloride inhibits “hyperactive” sodium channels and prevents the mucous membranes from drying out

Using the mouse model he developed, Dr. Marcus Mall, physician scientist and head of the Cystic Fibrosis Center at the Department of Pediatrics has shown that certain “hyperactive” sodium channels in airway cells are responsible for the increased absorption of salt and water from airway surfaces.

For the study, researchers tested whether inhibiting these hyperactive sodium channels with amiloride could improve hydration of the airway surfaces and prevent lung damage.

It was found that in a mouse model, amiloride administered in the first few days of life prevents the typical symptoms of cystic fibrosis and the development of chronic lung disease.

However, the treatment brought no improvement if the symptoms were already present

Chronic lung damage apparently prevents the amiloride from being effective.

“This indicates that the lung damage caused by the disease may be irreversible”, stated Dr. Mall.

“With amiloride, preventative therapy of cystic fibrosis that attacks the basic defect directly could be possible for the first time. But the children affected would have to be identified at a very early stage”, said Dr. Mall.

The study has been published in the “American Journal of Respiratory and Critical Care Medicine”. (ANI)

Why some people become fat and others don’t

London, Jan 19 (ANI): Researchers at Imperial College London, the French National Research Institute CNRS and other international institutions have discovered three new genetic variations that increase the risk of obesity, giving new insight into the reasons why some people become fat and others don’t.

They suggest that if each acted independently, these variants could be responsible for up to 50 percent of cases of severe obesity.

According to researchers, the new findings should ultimately provide the tools to predict which young children are at risk of becoming obese.

For the study, the researchers looked at the genetic makeup of obese children under six and morbidly obese adults, most of whom had been obese since childhood or adolescence, and compared this with age matched people of normal weight.

The researchers discovered three previously unidentified genetic variations that increase the risk of severe obesity significantly.

The gene variant most strongly linked to childhood obesity and adult morbid obesity in the study is located near the PTER gene, the function of which is not known.

This variant is estimated to account for up to a third of all childhood obesity, and a fifth of all cases of adult obesity.

The second variant linked to child and adult obesity is found in the NPC1 gene.

Previous studies in mice have suggested that this gene has a role in controlling appetite, as mice with a non-functioning NPC1 gene suffer late-onset weight loss and have poor food intake.

This gene variant accounts for around 10 per cent of all childhood obesity and about 14 per cent of adult morbid obesity cases.

The final variant is found near the MAF gene, which controls the production of the hormones insulin and glucagon, as well as chains of amino acids called glucagon-like peptides.

These hormones and peptides are known to play key roles in people’s metabolisms by metabolising glucose and carbohydrates in the body. Also, glucagon and glucagon-like peptides appear to have a strong effect on people’s ability to feel ‘full’ or satiated after eating.

This variant accounts for about 6 per cent of early-onset obesity in children, and 16 per cent of adult morbid obesity.

The researchers reached their conclusions by conducting a genome-wide association study of 1,380 Europeans with early-onset childhood obesity and adult morbid obesity, and 1,416 age-matched normal weight controls.

The study revealed 38 genetic markers with a strong association to a higher than normal body mass index, which the researchers evaluated in 14,186 Europeans, identifying three mutations that are significantly linked to obesity.

The study is published in the journal Nature Genetics. (ANI)